Docetaxel and cyclophosphamide cyclophosphamide epirubicin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy6

Bone Marrow Cell Line, Tumor Spleen Antilymphocyte Serum Lymph Nodes Esophagogastric Junction

Organisms5

Mice, Inbred BALB C Mice, Inbred Strains Mice, Inbred C3H Mice, Nude Mice, Inbred C57BL

Diseases63

Breast Neoplasms Leukopenia Neutropenia Lymphoma, Non-Hodgkin Neoplasm Metastasis Alopecia Lung Neoplasms Cystitis Hematologic Diseases Vomiting Nausea Wegener Granulomatosis Lupus Nephritis Lymphatic Metastasis Adenocarcinoma Neoplasm Recurrence, Local Neoplasms Recurrence Disease Progression Prostatic Neoplasms Stomatitis Carcinoma, Small Cell Anemia, Aplastic Stomach Neoplasms Ovarian Neoplasms Bone Neoplasms Lymphoma, Large B-Cell, Diffuse Amenorrhea Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Thrombocytopenia Leukemia, Lymphocytic, Chronic, B-Cell Carcinoma, Non-Small-Cell Lung Graft vs Host Disease Microscopic Polyangiitis Asthenia Lymphoma Hodgkin Disease Multiple Myeloma Lymphoma, Follicular Soft Tissue Neoplasms Lung Diseases, Interstitial Nephrotic Syndrome Neoplasms, Experimental Vasculitis Hypersensitivity, Delayed Polyarteritis Nodosa Bone Marrow Diseases Carcinoma Neoplasms, Second Primary Sarcoma, Experimental Leukemia L1210 Sarcoma Heart Diseases Lymphoma, B-Cell Agranulocytosis Churg-Strauss Syndrome Carcinoma, Ductal, Breast Primary Ovarian Insufficiency Lupus Erythematosus, Systemic Rhabdomyosarcoma Mammary Neoplasms, Experimental Infection Leukemia

Chemicals and Drugs86

Cyclophosphamide Epirubicin Taxoids Doxorubicin Vincristine Phosphoramide Mustards Antineoplastic Agents, Alkylating Fluorouracil Paclitaxel Prednisone Methotrexate Antibiotics, Antineoplastic Antineoplastic Agents, Phytogenic Granulocyte Colony-Stimulating Factor Cisplatin Etoposide Immunosuppressive Agents Antineoplastic Agents Thiotepa Busulfan Prednisolone Deoxycytidine Antibodies, Monoclonal, Murine-Derived Ifosfamide Vinblastine Mitoxantrone Vidarabine Anthracyclines Carboplatin Methylprednisolone Carmustine Razoxane Melphalan Azathioprine Mesna Bleomycin Antibodies, Monoclonal Chlorambucil Receptor, erbB-2 Acrolein Antibodies, Monoclonal, Humanized Alkylating Agents Dexamethasone Procarbazine Cytarabine Tamoxifen Estramustine Amifostine Vindesine Tegafur Myeloablative Agonists Antilymphocyte Serum Mechlorethamine Prodrugs Recombinant Proteins Antiemetics Tumor Markers, Biological Antimetabolites, Antineoplastic Mycophenolic Acid Antibodies, Antineutrophil Cytoplasmic Receptors, Estrogen Leucovorin Cytochrome P-450 CYP2B1 Lomustine Organothiophosphorus Compounds Misonidazole Antineoplastic Agents, Hormonal Bridged Compounds Mitomycins Glucocorticoids Mutagens Thalidomide Prolyl Hydroxylases Etanidazole Oxonic Acid Boronic Acids Cyclosporine Pyrazines Cladribine Indazoles Daunorubicin Topotecan P-Glycoprotein Organoplatinum Compounds Pentostatin Prostate-Specific Antigen

Analytical, Diagnostic and Therapeutic Techniques and Equipment63

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Combined Modality Therapy Disease-Free Survival Chemotherapy, Adjuvant Pulse Therapy, Drug Survival Analysis Survival Rate Remission Induction Infusions, Intravenous Neoadjuvant Therapy Neoplasm Staging Bone Marrow Transplantation Drug Therapy, Combination Transplantation, Autologous Maximum Tolerated Dose Hematopoietic Stem Cell Transplantation Follow-Up Studies Whole-Body Irradiation Administration, Metronomic Transplantation Conditioning Immunosuppression Prognosis Administration, Oral Hematopoietic Stem Cell Mobilization Prospective Studies Leukocyte Count Injections, Intravenous Drug Evaluation Mastectomy, Radical Transplantation, Homologous Feasibility Studies Kaplan-Meier Estimate Retrospective Studies Salvage Therapy Clinical Trials as Topic Neoplasm Transplantation Actuarial Analysis Random Allocation Area Under Curve Pilot Projects Mastectomy Leukapheresis Neoplasms, Experimental Plasmapheresis Tumor Burden Immunization, Passive Xenograft Model Antitumor Assays Sarcoma, Experimental Bone Marrow Purging Platelet Count Blood Cell Count Radiotherapy, Adjuvant Drug Screening Assays, Antitumor Peripheral Blood Stem Cell Transplantation Immunotherapy Proportional Hazards Models Induction Chemotherapy Mammary Neoplasms, Experimental Probability Randomized Controlled Trials as Topic Multivariate Analysis

Phenomena and Processes19

Dose-Response Relationship, Drug Maximum Tolerated Dose Time Factors Drug Resistance, Neoplasm Leukocyte Count Drug Synergism Biotransformation Premenopause Area Under Curve Drug Interactions Cell Survival Platelet Count Blood Cell Count Graft Survival Antibody Formation Apoptosis Drug Resistance Probability Drug Resistance, Multiple

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Humanities1

Quality of Life

Information Science1

Health Care18

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Follow-Up Studies Prospective Studies Feasibility Studies Kaplan-Meier Estimate Retrospective Studies Clinical Trials as Topic Actuarial Analysis Random Allocation Area Under Curve Pilot Projects Proportional Hazards Models Probability Randomized Controlled Trials as Topic Multivariate Analysis

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Health Care

Cyclophosphamide Epirubicin Taxoids Antineoplastic Combined Chemotherapy Protocols Doxorubicin Drug Administration Schedule Vincristine Phosphoramide Mustards Breast Neoplasms Antineoplastic Agents, Alkylating Fluorouracil Paclitaxel Prednisone Treatment Outcome Methotrexate Antibiotics, Antineoplastic Combined Modality Therapy Disease-Free Survival Antineoplastic Agents, Phytogenic Chemotherapy, Adjuvant Granulocyte Colony-Stimulating Factor Cisplatin Etoposide Immunosuppressive Agents Leukopenia Dose-Response Relationship, Drug Pulse Therapy, Drug Antineoplastic Agents Survival Analysis Neutropenia Thiotepa Survival Rate Remission Induction Infusions, Intravenous Busulfan Neoadjuvant Therapy Prednisolone Deoxycytidine Antibodies, Monoclonal, Murine-Derived Ifosfamide Lymphoma, Non-Hodgkin Vinblastine Neoplasm Metastasis Mitoxantrone Neoplasm Staging Vidarabine Bone Marrow Transplantation Anthracyclines Drug Therapy, Combination Carboplatin Alopecia Methylprednisolone Transplantation, Autologous Maximum Tolerated Dose Time Factors Hematopoietic Stem Cell Transplantation Lung Neoplasms Follow-Up Studies Cystitis Whole-Body Irradiation Administration, Metronomic Hematologic Diseases Vomiting Carmustine Transplantation Conditioning Razoxane Melphalan Nausea Drug Resistance, Neoplasm Immunosuppression Azathioprine Wegener Granulomatosis Lupus Nephritis Prognosis Mesna Lymphatic Metastasis Administration, Oral Bleomycin Adenocarcinoma Hematopoietic Stem Cell Mobilization Neoplasm Recurrence, Local Prospective Studies Neoplasms Antibodies, Monoclonal Recurrence Leukocyte Count Chlorambucil Receptor, erbB-2 Disease Progression Injections, Intravenous Acrolein Drug Evaluation Antibodies, Monoclonal, Humanized Drug Synergism Mastectomy, Radical Transplantation, Homologous Biotransformation Alkylating Agents Feasibility Studies Dexamethasone

No FAQ available that match "docetaxel and cyclophosphamide cyclophosphamide epirubicin"